COVID-19 and clinical research at NUH

COVID-19 and clinical research at NUH

Leading research into COVID-19

Early in 2020, we diverted our clinical research resources to lead high priority COVID-19 studies at NUH. Our research was part of the UK-wide efforts to identify and test potential treatments and vaccines to help save lives.

NUH was part of national and international research studies to rapidly develop new treatments and to build and share our knowledge of Coronavirus.

Research prioritisation process

Focussing our resources, skills snd expertise on COVID-19 meant prioritising what research we did. We followed the National Institute for Health and Care Research (NIHR) processes available on their website

Nottingham Health Science Partners

To coordinate COVID-19 research in Nottingham, we also established a Research Prioritisation Committee through Nottingham Health Science Partners.

Made up of our leading clinicians and academics, the Committee reviewed COVID-19 proposals on behalf of NUH and the University of Nottingham. Full details of the Committee's role, process and the form for researchers to submit Expressions of Interest for COVID-19 research are available in our online document library.

Finding treatments for COVID-19

NUH led a number of clinical research trials investigating potential treatments and vaccines for patients. These trials involved patients who were admitted to NUH with COVID-19 or suspected COVID-19 and NUH and frontline healthcare staff.